Thrilled to present the results of our study on #DCB based LAD PCI at #TCT2023 in San Francisco and to see the full paper simultaneously published on CircInterventions One more piece of evidence that supports the use of a #DCB based treatment for diffuse coronary artery disease.

Our editorial with Antonio Colombo on #TAVR adoption across the Atlantic just out JACC Journals, with new encouraging data from PARTNER3 & Evolut Low risk TCT Conference 🔗 shorturl.at/lVX35 🔗 Prosperi-Porta et al. shorturl.at/hoR14

Happy to share our latest publication led by co-first authors Jeremy Miles & Andrea Scotti just out in Circulation ahajournals.org/doi/10.1161/CI… We found: ➡️Heterogeneity of mortality risk in patients with LDL-C ≥190mg/dl. ➡️Undertreatment w/ 25% not prescribed statin therapy & 55%

Limited evidence from randomized controlled trials exists comparing drug-coated balloons to the latest generation of drug-eluting stents for the treatment of patients with de novo coronary lesions. This debate examines the pros and cons of employing drug-coated balloons in this

🔹EIJ DEBATES🔹 Drug-coated balloons as a first choice for patients with de novo lesions Pros: Antonio Colombo; Pier Pasquale Leone Cons: Clemens Von Birgelen; Eline H. Ploumen ow.ly/gnNX50Qvz9X

Additional pieces of information on which THV device to use for TAVI in patients with small aortic annuli. A nice complement to the the smart trial. Do we prefer a lower gradient or a lower rate of PVL? EuroIntervention #EIJBestOf Pier Pasquale Leone Azeem Latib

📣Our study from the RECOVERY TAVR registry is out on AmericanHeartJ 🌐 963 TAVR patients. 18% of PPM 📌PPM post TAVR is associated with adverse remodelling and left ventricle disfunction 📌Patients with PPM had higher NYHA class at FU Check it out! 👉🏻sciencedirect.com/science/articl…

Our piece with Bernardo Cortese Antonio Colombo on 2-year outcomes after sirolimus-coated 🎈 among 2,123 patients from the largest EASTBOURNE Registry finally out on EuroIntervention. Very promising low event accrual between 1 and 2 years. 🔗: shorturl.at/SXH2u

Enjoyed writing this piece with Antonio Colombo on 🔑 technical aspects of DCB PCI for CAD. A pleasure to share the chapter on specialty balloons with Matteo Maurina Valeria Paradies Ottavia Cozzi antonio mangieri Gabriele Gasparini Damiano Regazzoli Full text: shorturl.at/ks3V4

The EASTBOURNE Registry reveals 2-year outcomes for sirolimus-coated balloon angioplasty in coronary artery disease, showing low rates of target lesion revascularization and major adverse cardiac event. Pier Pasquale Leone Bernardo Cortese ow.ly/p4py50SwsMh

Pier Pasquale Leone, MD (Pier Pasquale Leone), and Antonio Colombo, MD (Antonio Colombo), highlight tips and methodology for optimizing PCI with drug-coated balloons. citoday.com/articles/2024-…